StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.34+0.00 (0.00%)

Close on Nov 17, 2026Market cap $65.96MP/E –Yield –

MediciNova ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

MediciNova's ebitda for the twelve months ending Jun 30, 2026 was -$11.83M. For fiscal 2025 it was -$13.26M. The highest annual figure on record is -$3.92M in fiscal 2013.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.26M–
FY2024Dec 31, 2024-$12.65M–
FY2023Dec 31, 2023-$9.88M–
FY2022Dec 31, 2022-$14.61M–
FY2021Dec 31, 2021-$10.19M–
FY2020Dec 31, 2020-$14.16M–
FY2019Dec 31, 2019-$14.01M–
FY2018Dec 31, 2018-$15.56M–
FY2017Dec 31, 2017-$13.00M–
FY2016Dec 31, 2016-$10.87M–
FY2015Dec 31, 2015-$8.80M–
FY2014Dec 31, 2014-$9.18M–
FY2013Dec 31, 2013-$3.92M–
FY2012Dec 31, 2012-$10.88M–
FY2011Dec 31, 2011-$16.07M–
FY2010Dec 31, 2010-$17.77M–
FY2009Dec 31, 2009-$21.02M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.54M–
Q1 FY2026Mar 31, 2026-$2.83M–
Q4 FY2025Dec 31, 2025-$3.09M–
Q3 FY2025Sep 30, 2025-$3.38M–
Q2 FY2025Jun 30, 2025-$3.60M–
Q1 FY2025Mar 31, 2025-$3.20M–
Q4 FY2024Dec 31, 2024-$3.18M–
Q3 FY2024Sep 30, 2024-$3.30M–
Q2 FY2024Jun 30, 2024-$3.04M–
Q1 FY2024Mar 31, 2024-$3.13M–
Q4 FY2023Dec 31, 2023-$2.48M–
Q3 FY2023Sep 30, 2023-$1.14M–
Q2 FY2023Jun 30, 2023-$3.30M–
Q1 FY2023Mar 31, 2023-$2.96M–
Q4 FY2022Dec 31, 2022-$3.23M–
Q3 FY2022Sep 30, 2022-$3.89M–
Q2 FY2022Jun 30, 2022-$4.09M–
Q1 FY2022Mar 31, 2022-$3.41M–
Q4 FY2021Dec 31, 2021-$2.10M–
Q3 FY2021Sep 30, 2021-$3.59M–
Q2 FY2021Jun 30, 2021-$4.30M–
Q1 FY2021Mar 31, 2021-$195.08K–
Q4 FY2020Dec 31, 2020-$3.01M–
Q3 FY2020Sep 30, 2020-$3.72M–
Q2 FY2020Jun 30, 2020-$4.51M–
Q1 FY2020Mar 31, 2020-$2.92M–
Q4 FY2019Dec 31, 2019-$2.22M–
Q3 FY2019Sep 30, 2019-$2.64M–
Q2 FY2019Jun 30, 2019-$4.18M–
Q1 FY2019Mar 31, 2019-$4.97M–
Q4 FY2018Dec 31, 2018-$486.14K–
Q3 FY2018Sep 30, 2018-$7.02M–
Q2 FY2018Jun 30, 2018-$3.39M–
Q1 FY2018Mar 31, 2018-$4.66M–
Q4 FY2017Dec 31, 2017-$3.40M–
Q3 FY2017Sep 30, 2017-$3.78M–
Q2 FY2017Jun 30, 2017-$2.80M–
Q1 FY2017Mar 31, 2017-$3.02M–
Q4 FY2016Dec 31, 2016-$1.44M–
Q3 FY2016Sep 30, 2016-$2.84M–

More MediciNova figures

See a number that looks wrong?